Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

Tomas Oestergaard JensenGreg A GranditsMamta K JainThomas A MurrayBirgit GrundKathryn Shaw-SalibaMichael A MatthayMahsa AbassiMagdalena ArdeltJason V BakerPeter ChenRobin L DewarAnna L GoodmanTimothy J HatlenHelene C HighbargerMark HolodniyPerrine LallemandSylvain LaverdureBradley G LeshnowerDavid LooneyCharalampos D MoschopoulosHenry MugerwaDaniel D MurrayEleftherios MylonakisStephanie Nagy-AgrenM Tauseef RehmanAdam RupertRandy A StevensStuart TurvilleAmy WeintrobKatherine WickJens Dilling LundgrenEmily R Konull null

Published in: The Journal of infectious diseases (2023)

NCT04501978.

Keyphrases

monoclonal antibody
end stage renal disease
coronavirus disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
depressive symptoms
peritoneal dialysis
hiv infected
dengue virus
replacement therapy
respiratory syndrome coronavirus